First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms

Clinical trial NCT07752121 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07752121
Sponsor: Bristol-Myers Squibb
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Myelodysplastic Neoplasms

Start date: 2026-08-24
Primary completion: 2030-08-31
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.